NASDAQ:BBNX Beta Bionics (BBNX) Stock Price, News & Analysis $14.68 +0.25 (+1.73%) As of 11:14 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Beta Bionics Stock (NASDAQ:BBNX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Beta Bionics alerts:Sign Up Key Stats Today's Range$14.28▼$15.1450-Day Range$9.71▼$15.8452-Week Range$8.89▼$24.50Volume41,788 shsAverage Volume476,316 shsMarket Capitalization$636.47 millionP/E RatioN/ADividend YieldN/APrice Target$24.83Consensus RatingModerate Buy Company OverviewBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Read More… Receive BBNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Stock News HeadlinesBeta Bionics, Inc. (BBNX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comBeta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025May 10, 2025 | finanznachrichten.deDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.May 29, 2025 | Colonial Metals (Ad)Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025May 6, 2025 | globenewswire.comBeta Bionics to Present at the Bank of America Securities Health Care ConferenceMay 1, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX)April 24, 2025 | finance.yahoo.comBeta Bionics: Slowing Down Or Being Conservative?April 24, 2025 | seekingalpha.comBeta Bionics to Host Investor Event on June 22, 2025April 9, 2025 | globenewswire.comSee More Headlines BBNX Stock Analysis - Frequently Asked Questions How have BBNX shares performed this year? Beta Bionics' stock was trading at $23.81 on January 1st, 2025. Since then, BBNX stock has decreased by 38.6% and is now trading at $14.62. View the best growth stocks for 2025 here. How were Beta Bionics' earnings last quarter? Beta Bionics, Inc. (NASDAQ:BBNX) issued its quarterly earnings results on Tuesday, May, 6th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.01. Read the conference call transcript. When did Beta Bionics IPO? Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share. When does Beta Bionics' lock-up period expire? Beta Bionics' lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. After the end of Beta Bionics' lock-up period, company insiders and major shareholders will be able to sell their shares of the company. Who are Beta Bionics' major shareholders? Beta Bionics' top institutional investors include Eventide Asset Management LLC (11.37%), Wellington Management Group LLP (9.00%), Sands Capital Ventures LLC (7.16%) and Omega Fund Management LLC (4.59%). Insiders that own company stock include Hadley Harbor Aggre Wellington and Mike Mensinger. View institutional ownership trends. How do I buy shares of Beta Bionics? Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2025Today5/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BBNX Previous SymbolNASDAQ:BBNX CIK1674632 WebN/A Phone(949) 427-7785FaxN/AEmployees294Year FoundedN/APrice Target and Rating Average Stock Price Target$24.83 High Stock Price Target$30.00 Low Stock Price Target$20.00 Potential Upside/Downside+69.2%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$69.83 million Price / Sales9.11 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares43,356,000Free FloatN/AMarket Cap$636.47 million OptionableN/A BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:BBNX) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.